Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Methadone maintenance and state Medicaid managed care programs.

D McCarty1, R G Frank, G C Denmead

  • 1Brandeis University, USA. mccarty@brandeis.edu

The Milbank Quarterly
|October 20, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Personal Psychedelic Experience as a Training Qualification for Facilitators: A Thematic Analysis of Qualitative Interviews with Psilocybin Experts.

Journal of psychoactive drugs·2024
Same author

Canadian Surgery Forum 2018: St. John's, NL Sept. 13-15, 2018.

Canadian journal of surgery. Journal canadien de chirurgie·2022
Same author

Development and validation of health system performance measures for opioid use disorder in British Columbia, Canada.

Drug and alcohol dependence·2022
Same author

Introduction-Special issue: Functional outcomes in rehabilitation.

NeuroRehabilitation·2014
Same author

Neuropsychological assessment in rehabilitation: Current limitations and applications.

NeuroRehabilitation·2014
Same author

Introduction.

NeuroRehabilitation·2014

Medicaid coverage for methadone services, a key therapy for heroin dependence, is limited in most states. Many state Medicaid plans do not cover methadone maintenance medication, hindering access to essential opioid use disorder treatment.

Area of Science:

  • Health Services Research
  • Substance Abuse Treatment
  • Public Health Policy

Background:

  • Methadone is a highly effective medication for treating heroin dependence.
  • Access to methadone services is crucial for individuals with opioid use disorder.
  • State Medicaid plans play a significant role in healthcare access for vulnerable populations.

Purpose of the Study:

  • To assess the extent of methadone services coverage within state Medicaid plans.
  • To identify limitations and barriers to methadone treatment access through Medicaid.
  • To inform policy recommendations for improving methadone service accessibility.

Main Methods:

  • Review of state Medicaid plan documents.
  • Analysis of coverage for methadone services and benefits in managed care.

Related Experiment Videos

  • Examination of limitations imposed on methadone treatment.

    • Main Results:

    • Methadone maintenance medication is not covered by Medicaid in 59% of states.
    • Only 24% of states include methadone services in Medicaid managed care plans.
    • Some states with coverage impose limitations on medication or counseling, or allow managed care plans to set limits.

    Conclusions:

    • Significant gaps exist in Medicaid coverage for methadone services, limiting access to effective heroin dependence treatment.
    • Collaboration between state Medicaid and substance abuse authorities is needed to ensure comprehensive coverage and appropriate payment mechanisms.
    • Policy interventions are required to remove barriers and incentivize enrollment for opioid-dependent individuals in Medicaid programs.